Literature DB >> 17257376

Establishment and characterization of a cell line derived from a human serous surface papillary carcinoma of the ovary.

Yoichi Kobayashi1, Hiroshi Mizuhara, Tatsuru Ohara, Haruhiro Kondo, Sojiro Sato, Kazushige Kiguchi, Bunpei Ishizuka, Isamu Ishiwata, Mamoru Tadokoro.   

Abstract

A novel serous surface papillary carcinoma of the ovary (SSPC) cell line, HYKSSPC, was established successfully. Carcinoma cells were obtained from ascitic fluid of a 60-year-old Japanese woman. The population doubling time was 51.4 h. A phase contrast micrograph showed a pavement stone-like arrangement without contact inhibition. The chromosome number showed a wide distribution of aneuploidy, and the mode was in 46-47. An immunocytochemical study showed that CA125, BerER4 and cytokeratin were positive and that CEA, calretinin and thrombomodulin were negative. This cell line preserved some characters of the adenocarcinoma while growing in vitro. A chemosensitivity test revealed that HYKSSPC cells were sensitive to CDDP (cis-platinum), 5-fluorouracil, mitomycin C, paclitaxel and irinotecan. To our knowledge, HYKSSPC is the first established cell line derived from SSPC, and it may offer some useful information for investigating this disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17257376     DOI: 10.1111/j.1749-0774.2006.00021.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  6 in total

1.  Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report.

Authors:  M SWERDLOW
Journal:  Am J Obstet Gynecol       Date:  1959-01       Impact factor: 8.661

2.  New chemosensitivity test using a thermo-reversible gelation polymer for recurrent gynecologic cancer patients and a preliminary study of mechanisms of anticancer drug resistance.

Authors:  Tatsuru Ohara; Kazushige Kiguchi; Satoshi Tsukikawa; Sojiro Sato; Yoichi Kobayashi; Bunpei Ishizuka; Sunao Kubota
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

3.  Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.

Authors:  G Dubernard; P Morice; A Rey; S Camatte; V Fourchotte; A Thoury; C Pomel; P Pautier; C Lhommé; P Duvillard; D Castaigne
Journal:  Eur J Surg Oncol       Date:  2004-11       Impact factor: 4.424

4.  Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma.

Authors:  R Halperin; S Zehavi; E Hadas; L Habler; I Bukovsky; D Schneider
Journal:  Int J Gynecol Pathol       Date:  2001-10       Impact factor: 2.762

5.  Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful.

Authors:  Robert J Barnetson; Rodney A Burnett; Ian Downie; Christina M Harper; Fiona Roberts
Journal:  Am J Clin Pathol       Date:  2006-01       Impact factor: 2.493

6.  Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study.

Authors:  Jeffrey D Bloss; Mark F Brady; Shu Yuan Liao; Thomas Rocereto; Edward E Partridge; Daniel L Clarke-Pearson
Journal:  Gynecol Oncol       Date:  2003-04       Impact factor: 5.482

  6 in total
  2 in total

1.  Establishment of a new cell line of endometrioid carcinoma of the ovary and its chemosensitivity.

Authors:  Tomokazu Umezu; Hiroaki Kajiyama; Mikio Terauchi; Kiyosumi Shibata; Kazuhiko Ino; Akihiro Nawa; Fumitaka Kikkawa
Journal:  Hum Cell       Date:  2007-08       Impact factor: 4.174

2.  In vivo modeling of metastatic human high-grade serous ovarian cancer in mice.

Authors:  Olga Kim; Eun Young Park; David L Klinkebiel; Svetlana D Pack; Yong-Hyun Shin; Zied Abdullaev; Robert E Emerson; Donna M Coffey; Sun Young Kwon; Chad J Creighton; Sanghoon Kwon; Edmund C Chang; Theodore Chiang; Alexander N Yatsenko; Jeremy Chien; Dong-Joo Cheon; Yang Yang-Hartwich; Harikrishna Nakshatri; Kenneth P Nephew; Richard R Behringer; Facundo M Fernández; Chi-Heum Cho; Barbara Vanderhyden; Ronny Drapkin; Robert C Bast; Kathy D Miller; Adam R Karpf; Jaeyeon Kim
Journal:  PLoS Genet       Date:  2020-06-04       Impact factor: 5.917

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.